364 related articles for article (PubMed ID: 15659871)
1. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
Badhe PB; Chauhan PP; Mehta NK
Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features of human brainstem gliomas.
Oka H; Utsuki S; Tanizaki Y; Hagiwara H; Miyajima Y; Sato K; Kusumi M; Kijima C; Fujii K
Brain Tumor Pathol; 2013 Jan; 30(1):1-7. PubMed ID: 22484454
[TBL] [Abstract][Full Text] [Related]
3. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
4. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
5. Surgical considerations for 'intrinsic' brainstem gliomas: proposal of a modification in classification.
Mehta VS; Chandra PS; Singh PK; Garg A; Rath GK
Neurol India; 2009; 57(3):274-81. PubMed ID: 19587467
[TBL] [Abstract][Full Text] [Related]
6. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
7. Brain stem gliomas: a clinicopathological study from a single cancer center.
Al-Hussaini M; Al-Jumaily U; Swaidan M; Musharbash A; Hashem S
Brain Tumor Pathol; 2013 Apr; 30(2):84-92. PubMed ID: 22752621
[TBL] [Abstract][Full Text] [Related]
8. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S
Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
[TBL] [Abstract][Full Text] [Related]
10. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 immunoreactivity in patients with glioma.
Kyritsis AP; Bondy ML; Hess KR; Cunningham JE; Zhu D; Amos CJ; Yung WK; Levin VA; Bruner JM
Clin Cancer Res; 1995 Dec; 1(12):1617-22. PubMed ID: 9815964
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
[TBL] [Abstract][Full Text] [Related]
14. Brainstem gliomas--retrospective analysis of 86 patients.
Ueoka DI; Nogueira J; Campos JC; Maranhão Filho P; Ferman S; Lima MA
J Neurol Sci; 2009 Jun; 281(1-2):20-3. PubMed ID: 19345380
[TBL] [Abstract][Full Text] [Related]
15. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.
Gilbertson RJ; Hill DA; Hernan R; Kocak M; Geyer R; Olson J; Gajjar A; Rush L; Hamilton RL; Finkelstein SD; Pollack IF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3620-4. PubMed ID: 14506149
[TBL] [Abstract][Full Text] [Related]
16. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
17. [A clinicopathological study of nine cases of midbrain glioma].
Nitta T; Sato K
No Shinkei Geka; 1995 May; 23(5):405-10. PubMed ID: 7753319
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
19. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
[TBL] [Abstract][Full Text] [Related]
20. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
